Shay Capital’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

Shay Capital’s Portfolio KRBP Stock Details KRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-577	Closed	-$7K	–	556
2022 Q2	$7K	Hold	577	–	–	﹤0.01%	412
2022 Q1	$15K	Hold	577	–	–	﹤0.01%	482
2021 Q4	$26K	Buy	577 +177	+44%	+$12.1K	﹤0.01%	454
2021 Q3	$37K	Sell	400 -433	-52%	-$44.8K	﹤0.01%	506
2021 Q2	$120K	Buy	+833	New	+$209K	0.01%	455

Other funds holding KRBP

ZCA

Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

RAM

Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

WealthTrust Axiom Wayne, Pennsylvania $406M AUM 40.44% 1-Year Est. Return

Shay Capital's KRBP Position: Q3 2022 in Review

Shay Capital sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q3 2022, closing a stake of 577 shares — an estimated $7K sold.

Shay Capital first reported a position in KRBP in Q2 2021 and held it in 5 quarters. The position peaked at $120K in Q2 2021. 16 funds tracked by Wall St. Rank hold KRBP as of Q3 2022.

Shay Capital reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Shay Capital sold 577 Kiromic BioPharma, Inc. Common Stock shares in Q3 2022, an estimated $7K.
Shay Capital first reported a position in Kiromic BioPharma, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
Shay Capital's Kiromic BioPharma, Inc. Common Stock position peaked at $120K in Q2 2021.
16 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q3 2022.

Based on Shay Capital's 13F filing for Q3 2022, filed 14 Nov 2022.